Dr. Kimberly Biss Speaks with Freedom Counsel

Dr. Kimberly Biss, a Florida‑based obstetrician, presented a striking trend at the IMA 2026 conference: her clinic’s miscarriage rate climbed from a baseline 4‑5% to 30% within two years after the COVID‑19 vaccine rollout. She traced the spike to patients who received the shots in 2021, noting that the elevated rates persisted into 2022 and early 2023 before gradually returning to normal. Biss took this data to Capitol Hill, testifying before Representative Marjorie Taylor‑Greene and other lawmakers, positioning the findings as a public‑health alarm.

The physician also warned that social‑media platforms, particularly Facebook, suppressed discussion of vaccine‑related fertility issues. She cited community groups like “My Cycle Story,” which were removed after posting about menstrual disruptions, early labor, and postpartum hemorrhage. According to Biss, the censorship discouraged many women from seeking alternative care, potentially increasing adverse outcomes. This narrative aligns with the broader medical‑freedom movement, which argues that patients should have unrestricted access to risk information and the ability to make autonomous reproductive choices.

Despite the urgency, Biss says research into spike‑protein effects on the uterine environment remains unfunded, as grant agencies deem the topic contrary to the prevailing safety narrative. She calls for direct assays to detect circulating spike protein in blood and for blood banks to screen donations for these markers. For investors and policymakers, the episode underscores a market gap in independent diagnostic tools and a regulatory risk landscape where emerging data may clash with established vaccine policy. Addressing these gaps could create new opportunities in reproductive health technology.